<![CDATA[Celltrion 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=10372>Fri, 01 May 2026 04:41:11 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Celltrion presents new two-year data for subcutaneous infliximab (CT-P13 SC) in inflammatory bowel disease (IBD) at the 19th ECCO Congress]]>https://www.newswire.co.kr/newsRead.php?no=984792Sun, 25 Feb 2024 10:15:00 +0900<![CDATA[Celltrion and MediGene Announce Co-development of Anti-L1 Monoclonal Antibody Therapeutic for Treating Cancer]]>https://www.newswire.co.kr/newsRead.php?no=300917Wed, 28 Nov 2007 11:28:47 +0900